undamentalytics Newsletter
Sign in

Science Applications International Corp (SAIC) stock

Add to watchlist

Add holding +

NASDAQ: SAIC Nasdaq IT Consulting & Other Services Next results ~December 3, 2026

C+ Fundamentals grade

Science Applications International Corporation (SAIC) provides technical, engineering and information technology (IT) services, chiefly to the United States government. Its work spans the design, development, integration, operation and sustainment of customers' IT systems. Named offerings include IT modernisation (cloud computing, cybersecurity and software), digital engineering, artificial intelligence, mission systems support for military weapon systems, training and simulation, and ground vehicles support. An internal unit it calls the Innovation Factory develops reusable solutions in AI, cloud and cybersecurity.

Its customers are almost entirely federal, including all the armed services, the Department of War (formerly the Department of Defense), NASA, the intelligence agencies, and the Departments of State, Justice and Homeland Security. SAIC is paid chiefly as a prime contractor or subcontractor, holding roughly 1,700 active contracts and task orders. Most fall under the Federal Acquisition Regulation, and many require staff to hold security clearances.

The company reports through two segments: Defense and Intelligence, serving national security customers, and Civilian, serving federal, state and local government. Nearly all of its business is based in the United States. SAIC has served the US government for over 50 years and employs about 23,000 people.

Based on Science Applications International Corp's 10-K filed March 16, 2026.

Stock price today

Loading chart…

Third-party market data · may be delayed

Fair value per share

~$110

Cash-flow model

Base case. Range ~$64–$160 across our lower- and higher-growth cases (-3%–7% a year).

Price vs value

Modestly overvalued

The price is inside our value range, 45% above our base value.

Price used: $152.91, November 2, 2026

Science Applications International Corp valuation: adjust assumptions and compare models →

Who’s trading

What company insiders, investment funds and members of Congress have been doing with the stock, from their own filings.

  • Insiders6 buying, 0 selling7 purchases and 0 sales by directors and officers, last 12 monthsInsider trades
  • Funds205 adding, 193 cuttingOf 43 active managers that changed their stake, 21 added; quarter to June 30, 2026Fund buyers and sellers

Value diary

Our note on each quarter Science Applications International files

Where Science Applications International stands after its latest 10-Q

Revenue for the twelve months to July 2026 was $7.40bn, down 0.8% on a year earlier, faster than -2.9% a quarter earlier. Free-cash-flow margin rose to 8.4% from 5.9% a year earlier. The diluted share count is down 7.8% on a year earlier, which lifts each remaining share. Against its peers on growth, profitability, cash generation and balance sheet, it grades C+. It passes 2 of our 5 financial-health checks. Our cash-flow model value is $108 a share, against a share price of $135. At that price, our model says the market is pricing in about 4.7% a year of cash-flow growth for five years, faster than the 0.0% a year revenue growth it has delivered.

Source: 10-Q filed August 31, 2026 on SEC EDGAR · Financials · Valuation

Written from the company's filings and our models when each quarter's report arrives. Figures in older notes are as published at the time. Not investment advice.

The Fundamentalytics view

Next results ~December 3, 2026 (estimated)

Science Applications International Corp's trailing-twelve-month revenue fell 0.8% year on year, with a free-cash-flow margin of 8.4%. Where it stands out: change in share count of -7.8% ranks 3 of 39 it consulting & other services companies we cover. Where it lags: long-term debt as % of assets of 45.2% ranks 26 of 27 it consulting & other services companies we cover.

Our discounted-cash-flow model values the business at ~$110 per share in the base case (~$64–$160 across growth scenarios) — model values under stated assumptions, not a price target.

Current signal Free cash flow diverging from earnings: TTM free cash flow grew 40.4% while net income fell 4.8%: a 45pp divergence.

Assembled from SEC-filed figures — the full workings are on this page and in our methodology. Observations, not recommendations.

Highlights

How we pick these

Strengths

  • Shrinking share count. Diluted shares fell 7.8% in a year, so each share owns more of the business.
  • Beating expectations. Earnings per share beat the analysts' consensus estimate in each of the last four quarters.

Things to watch

  • Priced above our value. The share price of $152.91 is 31% above our value per share of $110.
  • Revenue shrinking. Revenue fell 0.8% over the last 12 months.
  • Below peers: long-term debt as % of assets. Long-term debt as % of assets of 45.2% ranks 26 of 27 it consulting & other services companies we cover (median 11.8%).
  • Below peers: gross margin. Gross margin of 12.6% ranks 30 of 34 it consulting & other services companies we cover (median 28.2%).

Latest results: FY2027 Q2

Filed August 31, 2026
Earnings per share
$3.01 against an average estimate of $2.31: beat by 30.4%
Revenue
$1.88bn, up 6.3% on a year earlier
Share reaction
+0.7% in the first session after the results on August 31, 2026, against -1.0% for the S&P 500
Guidance given
revenue $7.2bn to $7.3bn (Fiscal Year 2027); organic Growth growth -2% to 0% (Fiscal Year 2027)
Next report
December 3, 2026; average EPS estimate $2.35

Science Applications International's figures from its SEC filings and results release; estimates are the analysts' average. Not a recommendation.

Price chart

  • 1 day+0.7%
  • 1 week+3.0%
  • 1 month+22.4%
  • This year+53.9%
  • 1 year+65.4%
  • 5 years+82.0%
  • S&P 500 this year+11.2%

Closing prices to 2026-11-02. Price change only, dividends excluded.

Loading chart…

Third-party market data · may be delayed

At a glance

Trailing twelve months, from SEC filings

Profitability

Revenue (TTM)
$7.4B
Operating margin
8.0%
Net margin
5.1%
EPS (TTM, diluted)
$8.53

Growth

Revenue growth
−0.8%
Change in growth rate
+2.1 pts
Share count change
−7.8%

Cash

Free cash flow (TTM)
$619M
FCF margin
8.4%
Stock pay % of revenue
0.9%

Earnings

Last results
August 31, 2026
Next results (est.)
November 23, 2026

News & updates

Updated November 3, 2026

Company announcements, filed results and changes that matter to shareholders.

  1. Announcement
  2. Leadership
  3. Results
  4. Guidance
  5. Announcement
  6. Agreement
  7. Leadership

Refreshed hourly when new source data is available. Summaries are checked against company releases and SEC filings. Company announcement headlines are labelled when a checked summary is unavailable.

Valuation

Science Applications International Corp valuation models and calculator

What the price is pricing in

The share price implies about 5.7% a year of cash-flow growth for five years.That is faster than the 0.0% a year revenue growth Science Applications International has delivered.

  • Priced in5.7%
  • Last 12 months-0.8%
  • 3 years a year-1.3%
  • 5 years a year0.0%

Our cash-flow model with every input fixed except growth over the next five years, solved for the growth at which the model value equals the share price ($148.76, Nov 3, 2026). Cash-flow growth then fades to 2.5% a year; discount rate 8.5%. Delivered figures are revenue growth from SEC filings. This is a model exercise, not investment advice or a forecast of the share price. All companies

Fundamentalytics rating

model v1.6 · 2026-11-03
Sell12-month view
12-month price target
~$110
Price used
$148.76close November 3, 2026
Implied change
▼ 29%
Uncertainty
High

How we got here: a discounted-cash-flow model of Science Applications International Corp's free cash flow after stock-based pay with after-tax interest added back ($419M, FY2027 Q2 TTM), growing -0.1% and 1.8% in the next two years (forecasts, guidance and its record), then back to 2% by year five, and fading to 2.5%, discounted at 8.5%. Lower and higher growth cases span ~$64–~$160 ; that spread sets a 35% margin before we rate Buy or Sell.

Produced by Fundamentalytics' automated valuation model on November 3, 2026, using delayed market prices. Rating meanings, methodology and conflicts: recommendations disclosure and research disclaimer. General research, not personal advice — it does not consider your circumstances. Prices can fall as well as rise.

Our value per share comes from a discounted-cash-flow model of Science Applications International Corp's free cash flow after stock-based pay ( $419M, FY2027 Q2 TTM, with after-tax interest added back): growth for five years as below (the first two years from forecasts, guidance and the company's record), fading to 2.5%, discounted at 8.5%, then cash added and debt and other claims subtracted. These are model values under stated assumptions, not price targets or recommendations.

Valuation models

We value Science Applications International Corp as an operating company, with every model that fits that kind of business. Cost of equity 8.5%: the 10-year Treasury yield (4.9%) plus a beta of 0.8 times a 4.5% equity risk premium.

Value per share by model
Model Value per share In the combined value?
Cash-flow model (DCF) Free cash flow to the firm (after stock pay, with after-tax interest added back), grown then faded to 2.5%, discounted at 8.5% as the firm rate, less debt and other claims. ~$110 ~$64–$160 Primary model, counts double
Forward price-to-earnings vs peers Next year's consensus earnings per share times peers' typical (harmonic-mean) forward price-to-earnings. Uses analysts' consensus estimates (third-party data), not our forecasts. ~$100 ~$95–$200 Included
Residual income Book value plus the present value of returns above the cost of equity, fading over ten years. ~$150 ~$100–$210 Included
Justified price-to-book Book value times (return on equity - growth) / (cost of equity - growth): steady-state returns. ~$120 ~$100–$150 Included
Combined value Weighted average of the models that apply: the primary model (cash-flow model (dcf)) counts double. Models more than 5x or less than 0.2x the share price, or more than 3x away from the other models' median, are left out. ~$120 ~$100–$150 4 models

Different models fail in different ways, so where several apply we average them rather than trust one. Peer-based models compare Science Applications International Corp with IT Consulting & Other Services in our coverage, using third-party market data. Model values are estimates under stated assumptions, updated as new filings arrive; not price targets or investment advice. How each model works.

What moves the value

  • Revenue growth 5 points lower ▼ −33%
  • Revenue growth 5 points higher ▲ +43%
  • Free-cash-flow margin 1 point lower ▼ −16%
  • Last year's free-cash-flow margin change, if it persists ▲ +62%
  • Discount rate 1 point higher ▼ −18%
Value per share under different assumptions
Discount rate ↓ / growth → −5% growth0% growth5% growth10% growth15% growth20% growth
7% $88$139$207$297$415$566
8.5% $54$91$140$205$288$396
10% $33$62$100$149$213$295

Valuation multiples over time Market data may be delayed

At fiscal year end 20162017201820192020202120222023202420252026Now
Share price$35.94$71.10$65.33$60.12$79.43$88.55$76.27$99.17$124.51$105.76$100.75$152.91
Market value$1.7bn$3.3bn$2.9bn$2.7bn$4.7bn$5.2bn$4.4bn$5.5bn$6.7bn$5.3bn$4.7bn$6.8bn
+ Net debt (− = net cash)−$195m−$210m−$144m−$237m−$188m−$171m−$106m−$109m−$94m−$56m−$182m$2.4bn
Enterprise value$1.5bn$3.1bn$2.8bn$2.4bn$4.5bn$5.0bn$4.3bn$5.4bn$6.6bn$5.3bn$4.5bn$9.2bn
Multiples
Price / sales 0.4x0.7x0.7x0.6x0.7x0.7x0.6x0.7x0.9x0.7x0.6x0.9x
Price / earnings 14.6x22.8x16.2x19.4x20.7x24.9x16.0x18.4x14.0x14.8x13.1x17.9x
Price / free cash flow 8.3x12.6x14.9x17.0x10.7x7.3x9.2x10.9x18.1x11.7x8.1x11.0x
EV / EBITDA 6.0x10.7x9.9x9.9x11.1x11.9x8.7x10.2x8.6x9.0x8.2x16.1x

Market value uses the period's diluted share count; figures for each fiscal year use that year's results and the price at year end. "Now" uses today's price and the last twelve months.

Moat

49 /100

Moderate moat

How hard Science Applications International's competitive advantage looks for rivals to wear away, judged from 10 years of its own filings: returns on capital, pricing power, profit durability, cash conversion and discipline.

  • Returns on capital 12 / 20

    Cash operating profit has been a median 9.9% of total assets over 5 years.

  • Pricing power 8 / 20

    Gross margin has been a median 11.5%, moving by 1.0 percentage points (standard deviation) across 10 years.

  • Durability 11 / 20

    Operating margin has been a median 6.3%; its worst year was 4.8%.

  • Cash conversion 13 / 20

    Free cash flow was positive in 10 of 10 years, at a median 6.2% of revenue.

  • Discipline 20 / 20

    The diluted share count fell 24.1% over five years; stock-based pay has been a median 0.6% of revenue.

AI disruption exposure: High. In this industry, the core product is information work that AI systems increasingly perform. The score above includes a 15-point deduction for that exposure (64 before it).

A rules-based reading of reported figures, not a forecast and not investment advice. How the score is built: methodology.

Forecasts and guidance

Next results: December 3, 2026, before the open. Analysts expect revenue of $1.8bn and EPS of $2.35 (range $2.27 to $2.41) for the quarter.

Analysts' consensus

Fiscal yearEPSGrowthRevenueGrowth
Current $10.81 +1% $7.3bn +1%
Next $11.49 +6% $7.4bn +1%

Next year's EPS estimate has moved +4.4% in 90 days, across 9 analysts.

How the EPS forecast has moved

The consensus EPS forecast for the current fiscal year is +6.3% on 90 days ago. In the last 30 days, 10 analysts raised Science Applications International Corp's forecast and 0 cut it.

Consensus EPS forecast Science Applications International Corp, last 90 days
$10.00 $10.50 $11.00 $11.50 90 days ago 60 days ago 30 days ago 7 days ago Now Current fiscal year, 90 days ago: $10.18 Current fiscal year, 60 days ago: $10.18 Current fiscal year, 30 days ago: $10.81 Current fiscal year, 7 days ago: $10.81 Current fiscal year, Now: $10.81 $10.81 Next fiscal year, 90 days ago: $11.00 Next fiscal year, 60 days ago: $11.00 Next fiscal year, 30 days ago: $11.48 Next fiscal year, 7 days ago: $11.49 Next fiscal year, Now: $11.49 $11.49

Average of analysts' published estimates (third-party data).

View chart data
Period Current fiscal yearNext fiscal year
90 days ago $10.18$11.00
60 days ago $10.18$11.00
30 days ago $10.81$11.48
7 days ago $10.81$11.49
Now $10.81$11.49

Earnings against estimates

Quarter toEstimateActualSurprise
Jul 2026 $2.31 $3.01 +30.4%
Apr 2026 $2.28 $3.23 +41.8%
Jan 2026 $2.01 $2.62 +30.0%
Oct 2025 $2.15 $2.58 +20.2%

Adjusted EPS as companies report it, against the average analyst estimate.

Management guidance

Earnings release, August 31, 2026
  • Revenue Fiscal Year 2027 $7.2bn to $7.3bn Raised
    “Revenue $7.2B - $7.3B $7.0B - $7.2B” source
  • Adjusted Diluted EPS Fiscal Year 2027 $10.65 to $10.75 Non-GAAP Raised
    “Adjusted Diluted EPS (1) $10.65 - $10.75 $9.90 - $10.10” source
  • Organic Growth Fiscal Year 2027 -2% growth to 0% growth Non-GAAP
    “Organic Growth (1) (2%) - (0%) (4%) - (2%)” source
  • Adjusted EBITDA Fiscal Year 2027 $750m to $755m Non-GAAP Raised
    “Adjusted EBITDA (1) $750M - $755M $720M - $730M” source
  • Adjusted EBITDA Margin % Fiscal Year 2027 10.3% to 10.5% Non-GAAP Raised
    “Adjusted EBITDA Margin % (1) 10.3% - 10.5% 10.1% - 10.3%” source
  • Free Cash Flow Fiscal Year 2027 about $600m Non-GAAP Maintained
    “Free Cash Flow (1) >$600M >$600M” source
Show 2 more items
  • Net cash provided by operating activities FY27 about $635m GAAP
    “Net cash provided by operating activities >$635M” source
  • Expenditures for property, plant, and equipment FY27 about $35m GAAP
    “Expenditures for property, plant, and equipment Approximately $35M” source

Figures and quotations are management's, copied from the company's own press release (SEC 8-K exhibit) and checked word for word against it. Forward-looking statements are the company's expectations, not ours and not advice; guidance can change or be missed.

How our valuation uses these forecasts

Our cash-flow model grows Science Applications International Corp's revenue by -0.1% next year and +1.8% the year after, then fades back toward its own record by year five. Next year's rate weighs analysts' consensus (-0.7%, weight 54%) , management guidance (-1.4%, weight 20%) and the company's own record (+2.0%, weight 26%) . How the weights are set.

Analyst recommendations

10 analysts, Nov 2026
Buy220%
Hold770%
Sell110%

Monthly trend

  1. Nov 202627110
  2. Oct 202628111
  3. Sep 202628111

Counts of recommendations published by analysts covering Science Applications International Corp, by month. Source: Aggregated broker recommendations (third-party data). Aggregated counts only: we do not reproduce any firm's recommendation or price target, and these are not Fundamentalytics ratings.

Positioning

Short interest
5.8%
of tradable shares
Days to cover
4.72
at average volume
Short interest, 1 month
−5%
to October 15, 2026
Held by institutions
91%
of shares
Held by insiders
0.8%
of shares
Employees
23,000
full time

Consensus figures average analysts' published estimates (third-party data); guidance is the company's own. Neither is our forecast. Short interest is reported twice a month and lags. Market data may be delayed.

This section is general information, not investment advice or a personal recommendation, and it does not take account of your objectives or circumstances. Forecasts and guidance are estimates, not promises: companies miss their own guidance and analysts' figures are often revised. Prices can fall as well as rise, and you can lose money. See our disclaimer.

Share-price performance

Market data may be delayed

What moved the share price

Last 12 months +65.4%

$92.47 on October 31, 2025 to $152.91

ThenNowEffect
Revenue (last 12 months) $7.5bn $7.4bn −0.8%
Net margin 5.3% 5.1% −4.0%
P/E multiple 11.2x 17.9x +60.1%
Share count 48m 45m +8.5%

Biggest factor: p/e multiple.

Last 3 years +43.2%

$106.77 on November 3, 2023 to $152.91

ThenNowEffect
Revenue (last 12 months) $7.7bn $7.4bn −3.7%
Net margin 6.5% 5.1% −20.9%
P/E multiple 11.7x 17.9x +52.7%
Share count 55m 45m +23.1%

Biggest factor: p/e multiple.

The effects multiply back to the price change exactly. Results are the last 12 months as known on each date (filings assumed public 45 days after quarter end).

Return and risk by year

Calendar year 202120222023202420252026 to date
Return
SAIC−10%+35%+14%−9%−9%+54%
Industry peers (median)+10%−35%+4%+24%−23%−16%
S&P 500+29%−18%+26%+25%+18%+11%
Months that ended higher
SAIC42%67%58%58%33%82%
S&P 50075%42%67%75%75%46%
Largest fall from a high during the year
SAIC−22%−15%−15%−29%−31%−28%
S&P 500−5%−25%−10%−8%−19%−9%

Worst fall since November 3, 2015: 46% from February 20, 2020 to March 23, 2020. Getting back needed a 85% gain, reached on December 3, 2020, 255 days after the low.

Price behaviour

52-week range
$81.40 – $152.91
From 52-week high
0.0%
vs 50-day average
+15.2%
vs 200-day average
+38.5%
Volatility (1 year)
39%
Beta vs S&P 500
0.13

Volatility is the annualised standard deviation of daily returns. Beta 1.5 means the shares typically moved 1.5% for each 1% move in the S&P 500 over the past year. Prices to November 2, 2026.

Share price after results

Next day
6 up, 6 down
typical move ±8.4%
After a week
6 up, 6 down
typical move ±8.0%
After a month
7 up, 5 down
typical move ±9.2%
Results releasedNext dayS&P 500 next day5 days21 days
August 31, 2026 +0.7% −1.0% +1.3% +1.3%
June 1, 2026 +8.8% +0.4% +8.6% +1.2%
March 16, 2026 +2.9% +1.3% +5.4% +5.1%
February 11, 2026 −14.8% −1.6% −7.0% −6.1%
December 4, 2025 +14.9% +0.3% +14.2% +24.3%
September 4, 2025 −8.0% +0.5% −6.8% −10.9%
June 2, 2025 −10.5% +1.1% −10.4% +1.7%
March 17, 2025 +8.6% −0.3% +4.5% +12.6%
December 5, 2024 −4.7% 0.0% −8.4% −8.0%
September 5, 2024 +3.0% −1.9% +4.4% +12.7%
June 3, 2024 −12.9% +0.2% −14.1% −13.6%
March 18, 2024 −11.2% +1.2% −10.8% −12.3%

From the close before the release date to the close 1, 5 and 21 trading days after it, so releases before the open and after the close are both captured. Past moves don't predict future ones.

Options strategies

All options ideas

How Science Applications International Corp’s listed options are priced, and three ways to use them that follow from our valuation. Quotes are delayed, read November 2, 2026. Check the live chain at your broker before trading.

Cash-secured put

Not offered: rated Sell.

We suggest selling a put only on well-rated companies, at a strike where the price you would pay if assigned (strike less premium) is at or below our fair value.

Covered call

Not offered: no liquid call at or above our price target — the model says the upside is worth more than any listed strike.

For holders: sell a call at a strike at or above our fair value, so the shares are only sold at a price the model calls full value.

Collar

Not offered: no liquid put and call pair for the same expiry.

For holders of a stock trading at or above our fair value: buy a put for a floor and sell a call to pay for it.

General research, not personal advice. Options can lose you more than you expect and are not suitable for everyone: put sellers can be made to buy shares that keep falling, call sellers give up gains above the strike, and results or news can move prices sharply. Chances shown are approximations from each option’s delta. Spreads, fees and early assignment are not modelled.

Science Applications International Corp in five measures

Fundamentals grade C+
Growth Profitability Cash Balance sheet Value

Growth, profitability, cash generation and balance sheet are percentiles against the companies we cover in the same industry, from SEC filings (100 = best). Value compares the share price with our modelled value range (50 = at our base value; higher = cheaper). A description of reported data and our model — not a quality score or advice.

Fundamentals

Revenue (TTM) Science Applications International Corp
$7.2B $7.4B $7.6B $7.8B FY24 Q3 FY25 Q2 FY26 Q1 FY27 Q2 Revenue (TTM), FY24 Q3: $7.7B Revenue (TTM), FY24 Q4: $7.4B Revenue (TTM), FY25 Q1: $7.3B Revenue (TTM), FY25 Q2: $7.3B Revenue (TTM), FY25 Q3: $7.4B Revenue (TTM), FY25 Q4: $7.5B Revenue (TTM), FY26 Q1: $7.5B Revenue (TTM), FY26 Q2: $7.5B Revenue (TTM), FY26 Q3: $7.4B Revenue (TTM), FY26 Q4: $7.3B Revenue (TTM), FY27 Q1: $7.3B Revenue (TTM), FY27 Q2: $7.4B $7.4B

Source: SEC EDGAR filings. Retrieved October 20, 2026.

View chart data
Period Revenue (TTM)
FY24 Q3 $7.7B
FY24 Q4 $7.4B
FY25 Q1 $7.3B
FY25 Q2 $7.3B
FY25 Q3 $7.4B
FY25 Q4 $7.5B
FY26 Q1 $7.5B
FY26 Q2 $7.5B
FY26 Q3 $7.4B
FY26 Q4 $7.3B
FY27 Q1 $7.3B
FY27 Q2 $7.4B
Revenue growth, TTM YoY Science Applications International Corp
-10% -5% 0% 5% FY24 Q3 FY25 Q2 FY26 Q1 FY27 Q2 Revenue growth, TTM YoY, FY24 Q3: 2.1% Revenue growth, TTM YoY, FY24 Q4: -3.4% Revenue growth, TTM YoY, FY25 Q1: -6.1% Revenue growth, TTM YoY, FY25 Q2: -5.1% Revenue growth, TTM YoY, FY25 Q3: -3.9% Revenue growth, TTM YoY, FY25 Q4: 0.5% Revenue growth, TTM YoY, FY26 Q1: 3.4% Revenue growth, TTM YoY, FY26 Q2: 2.2% Revenue growth, TTM YoY, FY26 Q3: -0.4% Revenue growth, TTM YoY, FY26 Q4: -2.9% Revenue growth, TTM YoY, FY27 Q1: -2.9% Revenue growth, TTM YoY, FY27 Q2: -0.8% -0.8%

Source: SEC EDGAR filings. Retrieved October 20, 2026.

View chart data
Period Revenue growth, TTM YoY
FY24 Q3 2.1%
FY24 Q4 -3.4%
FY25 Q1 -6.1%
FY25 Q2 -5.1%
FY25 Q3 -3.9%
FY25 Q4 0.5%
FY26 Q1 3.4%
FY26 Q2 2.2%
FY26 Q3 -0.4%
FY26 Q4 -2.9%
FY27 Q1 -2.9%
FY27 Q2 -0.8%
Operating margin (TTM) Science Applications International Corp
6% 7% 8% 9% 10% 11% FY24 Q3 FY25 Q2 FY26 Q1 FY27 Q2 Operating margin (TTM), FY24 Q3: 10.2% Operating margin (TTM), FY24 Q4: 10.0% Operating margin (TTM), FY25 Q1: 9.8% Operating margin (TTM), FY25 Q2: 6.7% Operating margin (TTM), FY25 Q3: 6.8% Operating margin (TTM), FY25 Q4: 7.5% Operating margin (TTM), FY26 Q1: 7.4% Operating margin (TTM), FY26 Q2: 7.5% Operating margin (TTM), FY26 Q3: 7.2% Operating margin (TTM), FY26 Q4: 7.2% Operating margin (TTM), FY27 Q1: 7.9% Operating margin (TTM), FY27 Q2: 8.0% 8.0%

Source: SEC EDGAR filings. Retrieved October 20, 2026.

View chart data
Period Operating margin (TTM)
FY24 Q3 10.2%
FY24 Q4 10.0%
FY25 Q1 9.8%
FY25 Q2 6.7%
FY25 Q3 6.8%
FY25 Q4 7.5%
FY26 Q1 7.4%
FY26 Q2 7.5%
FY26 Q3 7.2%
FY26 Q4 7.2%
FY27 Q1 7.9%
FY27 Q2 8.0%
FCF margin (TTM) Science Applications International Corp
4% 5% 6% 7% 8% 9% FY24 Q3 FY25 Q2 FY26 Q1 FY27 Q2 FCF margin (TTM), FY24 Q3: 5.9% FCF margin (TTM), FY24 Q4: 5.0% FCF margin (TTM), FY25 Q1: 5.3% FCF margin (TTM), FY25 Q2: 5.1% FCF margin (TTM), FY25 Q3: 5.6% FCF margin (TTM), FY25 Q4: 6.1% FCF margin (TTM), FY26 Q1: 6.1% FCF margin (TTM), FY26 Q2: 5.9% FCF margin (TTM), FY26 Q3: 5.8% FCF margin (TTM), FY26 Q4: 7.9% FCF margin (TTM), FY27 Q1: 8.3% FCF margin (TTM), FY27 Q2: 8.4% 8.4%

Source: SEC EDGAR filings. Retrieved October 20, 2026.

View chart data
Period FCF margin (TTM)
FY24 Q3 5.9%
FY24 Q4 5.0%
FY25 Q1 5.3%
FY25 Q2 5.1%
FY25 Q3 5.6%
FY25 Q4 6.1%
FY26 Q1 6.1%
FY26 Q2 5.9%
FY26 Q3 5.8%
FY26 Q4 7.9%
FY27 Q1 8.3%
FY27 Q2 8.4%

Data: SEC EDGAR XBRL company facts (as filed in 10-K/10-Q); forms 10-K, 10-Q. Generated November 3, 2026. Definitions in our methodology.

Where the money goes

FY2026, from the 10-K

Each dollar Science Applications International took in during FY2026, followed through to profit: what it cost to make, what went on running the business, and what was left after tax.

  1. Revenue $7.3B
  2. Cost of revenue $6.4B · 88.0%
  3. Gross profit $872M · 12.0%
  4. Selling, general and admin $350M · 4.8%
  5. Operating income $521M · 7.2%
  6. Interest and other $134M · 1.8%
  7. Net income $358M · 4.9%

Shares of revenue. Source: Science Applications International's 10-K for FY2026, as filed with the SEC. "Other" lines are what the reported lines leave unexplained.

Financial statements

US$ millions unless shown otherwise. Fiscal years, plus the last twelve months (LTM) when newer.

Fiscal year 2012 Jan 2012 2013 Jan 2013 2014 Jan 2014 2015 Jan 2015 2016 Jan 2016 2017 Feb 2017 2018 Feb 2018 2019 Feb 2019 2020 Jan 2020 2021 Jan 2021 2022 Jan 2022 2023 Feb 2023 2024 Feb 2024 2025 Jan 2025 2026 Jan 2026 LTM Jul 2026
Income
Revenue 4,733 4,781 4,121 3,885 4,315 4,442 4,454 4,659 6,379 7,056 7,394 7,704 7,444 7,479 7,262 7,402
Gross profit 426 408 333 335 411 439 411 464 706 792 859 888 872 892 872 936
EBITDA 314 291 194 259 253 286 279 243 406 422 499 533 767 588 551 569
Operating income 299 281 183 240 227 263 256 220 370 390 462 501 741 563 521 592
Net income 182 182 113 141 117 143 179 137 226 209 277 300 477 362 358 380
Diluted EPS $3.66 $3.66 $2.27 $2.91 $2.47 $3.12 $4.02 $3.11 $3.83 $3.56 $4.77 $5.38 $8.88 $7.17 $7.70 $8.53
Growth (year on year)
Revenue — +1.0% −13.8% −5.7% +11.1% +2.9% +0.3% +4.6% +36.9% +10.6% +4.8% +4.2% −3.4% +0.5% −2.9% −0.8%
EBITDA — −7.3% −33.3% +33.5% −2.3% +13.0% −2.4% −12.9% +67.1% +3.9% +18.2% +6.8% +43.9% −23.3% −6.3% +8.0%
Operating income — −6.0% −34.9% +31.1% −5.4% +15.9% −2.7% −14.1% +68.2% +5.4% +18.5% +8.4% +47.9% −24.0% −7.5% +6.1%
Net income — 0.0% −37.9% +24.8% −17.0% +22.2% +25.2% −23.5% +65.0% −7.5% +32.5% +8.3% +59.0% −24.1% −1.1% −4.8%
Diluted EPS — 0.0% −38.0% +28.2% −15.1% +26.3% +28.8% −22.6% +23.2% −7.0% +34.0% +12.8% +65.1% −19.3% +7.4% +3.3%
Margins
Gross margin 9.0% 8.5% 8.1% 8.6% 9.5% 9.9% 9.2% 10.0% 11.1% 11.2% 11.6% 11.5% 11.7% 11.9% 12.0% 12.6%
EBITDA margin 6.6% 6.1% 4.7% 6.7% 5.9% 6.4% 6.3% 5.2% 6.4% 6.0% 6.7% 6.9% 10.3% 7.9% 7.6% 7.7%
Operating margin 6.3% 5.9% 4.4% 6.2% 5.3% 5.9% 5.7% 4.7% 5.8% 5.5% 6.2% 6.5% 10.0% 7.5% 7.2% 8.0%
Net margin 3.8% 3.8% 2.7% 3.6% 2.7% 3.2% 4.0% 2.9% 3.5% 3.0% 3.7% 3.9% 6.4% 4.8% 4.9% 5.1%
Free-cash-flow margin 6.3% 5.7% 4.1% 6.6% 4.8% 5.8% 4.4% 3.3% 6.9% 10.0% 6.5% 6.6% 5.0% 6.1% 7.9% 8.4%
Cash flow
Cash from operations 303 280 183 277 226 273 217 184 458 755 518 532 396 494 609 660
Capital spending 6 7 16 22 20 15 22 28 21 46 36 25 27 36 32 41
Free cash flow 297 273 167 255 206 258 195 156 437 709 482 507 369 458 577 619
Stock-based pay 28 30 33 35 33 31 27 45 37 42 46 48 68 53 64 65
Free cash flow after stock pay 269 243 134 220 173 227 168 111 400 667 436 459 301 405 513 554
Balance sheet
Cash 1 1 254 301 195 210 144 237 188 171 106 109 94 56 182 126
Total debt 3 — — — — — — — — — — — — — — 2,499
Net debt (negative = net cash) 2 −1 −254 −301 −195 −210 −144 −237 −188 −171 −106 −109 −94 −56 −182 2,373
Diluted shares 50m 50m 50m 49m 47m 46m 45m 44m 59m 59m 58m 56m 54m 51m 47m 45m
Returned to shareholders
Dividends — — 295 52 55 54 54 53 87 87 86 83 79 75 70 67
Buybacks — — 13 149 69 180 186 69 197 34 226 267 382 558 445 479
Total returned — — 308 201 124 234 240 122 284 121 312 350 461 633 515 546

Source: SEC EDGAR XBRL company facts (US and foreign periodic filings); column headings link to the filing. EBITDA is operating income plus depreciation and amortisation. Free cash flow is cash from operations minus capital spending. Growth is left blank when last year's figure was a loss or under 2% of revenue. Share counts and EPS are restated for stock splits. A dash means the company didn't report the figure.

Financial health

2 of 5 checks passed · July 31, 2026
What it owns · $5.4bn
Short-term assets $1.3bnLonger-term assets $4.1bn
What it owes, and who funded it · $2.5bn
Short-term liabilities $1.1bnShareholders' equity $1.4bn
  • Short-term assets cover short-term liabilities $1.3bn of assets due within a year against $1.1bn of liabilities due within a year.
  • Short-term assets cover long-term liabilities Not assessable from the reported split. Not assessable.
  • More cash than debt $126m of cash against $2.5bn of debt.
  • Debt below 40% of shareholders' equity Debt is 173% of equity.
  • Debt burden no higher than five years ago Debt to equity moved from 146% to 173% over five years.
  • A year's operating cash flow covers at least 20% of debt $660m of operating cash flow against $2.5bn of debt.
  • Operating profit covers interest at least five times over Interest not separately reported. Not assessable.

From Science Applications International Corp's latest balance sheet as filed. Checks are fixed, documented rules (methodology), counted only where the company reports the figures — a dot means the filing doesn't break the item out. Descriptions of reported data, not advice.

Dividends, buybacks and capital spending

FY2027 Q2 TTM
Buybacks (TTM)
$479M
Dividends (TTM)
$67M
Returned to shareholders
88%
of free cash flow
Buybacks, last 3 fiscal years
$1.4B
Diluted share count
−7.8%
year over year
Total shareholder yield
8.5%
dividends 1.0% + buybacks 7.5% of market value
Dividend payout ratio
18%
of net income paid out
Sales & admin spending
4.8%
of revenue
Days sales outstanding
49 days
receivables vs revenue

Competitors: side by side with peers

Closest by revenue in it consulting & other services
Last 12 months unless stated SAIC IT EPAM CACI G BAH Median
Revenue, last 12 months $7.4bn $6.5bn $5.6bn $9.8bn $5.3bn $11.0bn $383m
Revenue growth, last 12 months −0.8% 0.7% 10.8% 10.1% 6.5% −6.2% 5.7%
Revenue growth, 3-year average −1.3% 4.0% 5.1% 12.0% 6.0% 3.1% 4.3%
Revenue growth, latest quarter 6.3% −0.6% 4.5% 8.2% 7.1% −3.9% 4.7%
Gross margin 12.6% 70.1% 29.4% 28.0% 36.5% 52.5% 28.0%
Operating margin 8.0% 17.3% 10.0% 9.8% 14.8% 9.3% 5.9%
Operating margin, 3-year average 7.4% 18.1% 10.3% 9.2% 14.7% 10.1% 7.5%
Net margin 5.1% 12.0% 7.2% 5.5% 11.1% 7.1% 2.2%
Cash from operations / revenue 8.9% 21.4% 9.6% 9.0% 12.3% 9.8% 6.7%
Free-cash-flow margin 8.4% 19.9% 8.6% 8.0% 10.5% 9.0% 5.0%
Free-cash-flow margin, 3-year average 6.5% 20.0% 9.5% 6.7% 10.6% 8.0% 6.7%
Stock pay / revenue 0.9% 2.3% 3.3% 0.9% 1.8% 0.7% 2.2%
Change in share count −7.8% −8.8% −4.8% −0.4% −2.8% −4.0% 0.9%

Median of all 40 companies we cover in it consulting & other services. Shaded: best of the six on that line (lowest for stock pay and share-count growth). 3-year figures average the last three 12-month periods; 3-year growth is compound annual. Source: SEC filings.

Peer comparison

40 it consulting & other services companies
Measure Company Peer median Rank
Revenue growth Growth -0.8% 6.5% 29 of 40
Change in growth rate Growth +2.1pp -0.8pp 8 of 40
Gross margin Profitability 12.6% 28.2% 30 of 34
Operating margin Profitability 8.0% 5.9% 14 of 36
Net margin Profitability 5.1% 2.5% 17 of 40
Free-cash-flow margin Cash generation 8.4% 5.1% 14 of 38
Stock pay as % of revenue Cash generation 0.9% 2.3% 7 of 36
Long-term debt as % of assets Balance sheet 45.2% 11.8% 26 of 27
Change in share count Balance sheet -7.8% 0.9% 3 of 39
Days sales outstanding Balance sheet 49 days 71 days 9 of 30

Rank 1 = best in the group (for spending, debt and dilution, lower ranks first).

Where the revenue comes from

Fiscal year to January 30, 2026
Segments
Line of business Revenue Share YoY
Defense and Intelligence $5.6B 76.9% ▼ 2.5%
Civilian $1.7B 23.1% ▼ 4.1%
Corporate $0 0.0% —

From Science Applications International Corp's 10-K filed March 16, 2026, as tagged in the filing. View filing. Indented rows are part of the line above; their share is of that line. In the bars, the faint bar behind is the year before.

Who owns it

Funds buying and selling
Reported value
$4B
Institutions reporting
431
Shares held vs prior quarter
▲ 0.8%
Positions opened / closed
57 / 46

Top buyers and sellers, Q2 2026: 205 institutions bought and 193 sold ; the biggest buyer was Fuller & Thaler Asset Management, Inc (+256K shares) and the biggest seller FMR LLC (−739K). See which funds bought and sold →

Largest reported holders, June 30, 2026
Manager Value Shares Share of 13F value Shares QoQ
Blackrock, Inc. $489M 4.4M 12.2% ▼ 2.6%
Fuller & Thaler Asset Management, Inc. $326M 3.0M 8.2% ▲ 9.5%
Vanguard Portfolio Management LLC $252M 2.3M 6.3% ▼ 4.2%
Vanguard Capital Management LLC $215M 1.9M 5.4% ▼ 3.7%
AQR Capital Management LLC $201M 1.8M 5.0% ▼ 15.0%
Dimensional Fund Advisors LP $188M 1.7M 4.7% ▲ 10.8%
First Trust Advisors LP $185M 1.7M 4.6% ▲ 11.7%
Invesco Ltd. $180M 1.6M 4.5% ▲ 9.9%
LSV Asset Management $174M 1.6M 4.4% ▲ 0.1%
State Street Corp $160M 1.5M 4.0% ▲ 1.1%
Geode Capital Management, LLC $136M 1.2M 3.4% ▲ 26.1%
Boston Partners $76.4M 692K 1.9% ▲ 11.9%

From Form 13F filings with the SEC ( quarterly data sets), as reported by each manager for June 30, 2026 and filed up to 45 days later. 13F reports cover long US-listed positions of managers above $100M only, so this is not Science Applications International Corp's complete shareholder register. Values are as reported by the filers .

Insider trading activity

Full insider history and chart
Insider purchases History → $478,718 7 trades by 6 insiders, last 12 months Insider sales History → $0 0 trades by 0 insiders
Net ▲ $478,718 net buying
Insider Date Trade Shares Price Value
Cush C. David Director September 22, 2026 Buy 1,000 $132.50 $132,500
Attili Srinivas EVP, Civilian April 9, 2026 Buy 100 $94.96 $9,496
Attili Srinivas EVP, Civilian December 31, 2025 Buy 100 $101.26 $10,126
Difronzo Vincent P. EVP,-Air Force & Comb Commands December 23, 2025 Buy 150 $102.89 $15,434
Natarajan Prabu EVP, Chief Financial Officer December 16, 2025 Buy 2,000 $100.49 $200,976
Reagan James Interim CEO December 16, 2025 Buy 1,000 $100.17 $100,165
Hageman Hilary EVP General Counsel, Secretary December 16, 2025 Buy 100 $100.21 $10,021

From insiders' Form 4 filings with the SEC. Excludes awards, option exercises and shares withheld for tax. "Pre-set plan" means the filing marks the trade as made under a Rule 10b5-1 plan. See every insider trade since five years ago, on a price chart.

Trades by members of Congress

All 21 trades and filings

No trades in Science Applications International Corp disclosed in the last 12 months; 21 earlier trades on record.

  • Lisa C. McClain(R-MI 9):Sale (full), $1,001 - $15,000, traded October 31, 2025, filed November 21, 2025
  • Lisa C. McClain(R-MI 9):Sale (full), $1,001 - $15,000, traded October 30, 2025, filed November 21, 2025
  • Lisa C. McClain(R-MI 9):Purchase, $1,001 - $15,000, traded October 30, 2025, filed November 21, 2025

Value ranges as filed; reports can arrive up to 45 days after a trade.

Earnings dates and SEC filings

Results announcements

Next expected around November 23, 2026 estimated from the company's past filing pattern, not announced

  • August 31, 2026
  • June 1, 2026
  • March 16, 2026
  • February 11, 2026
  • December 4, 2025
  • September 4, 2025

Recent SEC filings

Data status

When each part of this page on Science Applications International Corp was last updated.

DataLast updatedSource
Share priceExchange closing prices
Financial statementsSEC 10-K and 10-Q filings
News and updatesCompany releases and SEC 8-K filings
Analyst estimatesAggregated analyst estimates
Valuation and scoresOur models, from the filed figures

How we build and check these figures: methodology and data sources.

Science Applications International Corp in brief

What does Science Applications International Corp do?
Science Applications International Corp is a US-listed company in the IT consulting & other services industry. Its financial year ends in January.
What is Science Applications International Corp's stock ticker?
Science Applications International Corp trades under the ticker SAIC on Nasdaq. This page brings together its financial statements, valuation models, ownership and recent company updates.
What is Science Applications International Corp's revenue, and how fast is it growing?
Over its most recent trailing twelve months, Science Applications International Corp reported revenue of $7.4B, 0.8% lower than a year earlier, according to its SEC filings.
What is Science Applications International Corp's free cash flow?
Science Applications International Corp's free-cash-flow margin is 8.4% of revenue over the trailing twelve months, ranking 14 of the 38 it consulting & other services companies we cover.
What is Science Applications International Corp's fair value (intrinsic value) per share?
Our discounted-cash-flow model of Science Applications International Corp's free cash flow after stock-based pay gives ~$110 per share in the base case, and ~$64–$160 across growth scenarios. These are model values under stated assumptions — not a price target or a recommendation.
Who are Science Applications International Corp's largest institutional shareholders?
By value reported in 13F filings for June 30, 2026, the largest reported holders are Blackrock, Inc., Fuller & Thaler Asset Management, Inc. and Vanguard Portfolio Management LLC. 13F reports cover long US-listed positions of managers above $100M, filed up to 45 days after quarter end.
Is Science Applications International Corp buying back stock, and does it pay a dividend?
Science Applications International Corp spent $479M on share repurchases over the trailing twelve months, and its diluted share count fell 7.8% over the year.
What is Science Applications International Corp's market cap?
On November 2, 2026, Science Applications International Corp's market capitalisation was about $6.8B, with a price-to-earnings ratio of 17.9 and net debt of $2.4B. Market figures come from third-party market data and may be delayed.
Does Science Applications International Corp pay a dividend?
Yes: Science Applications International Corp paid $67M in dividends over the trailing twelve months, a dividend yield of 1.04% and a payout ratio of 17.6%.
How much debt does Science Applications International Corp have?
Science Applications International Corp's debt-to-equity ratio is 173.1%, from its latest balance sheet (146.4% five years earlier). The financial health section below sets out its other solvency checks.
Who are Science Applications International Corp's competitors?
In our IT Consulting & Other Services peer group, the companies closest to Science Applications International Corp are Gartner, EPAM Systems, Inc., CACI International Inc, Genpact LTD and Booz Allen Hamilton Holding Corp. The side-by-side comparison below sets their revenue, margins and growth against Science Applications International Corp's.
Are insiders buying or selling Science Applications International Corp stock?
Over the last 12 months, Science Applications International Corp's directors and officers reported 7 open-market purchases and 0 sales on Form 4. The insider trading page charts every trade.
When is Science Applications International Corp's next earnings date?
Around December 3, 2026, estimated from the spacing of its past results announcements (8-K filings). That is an estimate, not a confirmed date — Science Applications International Corp announces its own schedule.